Abstract:Hepatocellular carcinoma (HCC) is hallmarked by inflammatory cell infiltration. Chemokines secreted during inflammation are crucial at directing immune cell infiltration during cancer development. We screened patient dataset from different etiologies including HBV, HCV, alcohol and non-alcoholic steatohepatitis (NASH) and identified CXCL5 as the only chemokine consistently upregulated in HCC. Immunohistochemistry (IHC) of patient liver tumor tissues further showed the production of CXCL5 by tumor surrounding non parenchymal cells. Using a mouse model (Pte loxP/loxP; Alb-Cre+, Pten null) which recapitulates human liver disease progression from non-alcoholic fatty liver disease (NAFLD) to NASH to liver cancer, we found that CXCL5 was expression was gradually increased during disease progression. Further analysis using IHC and flow cytometry analysis showed that CXCL5 is predominantly expressed by Kupffer cells in Pten null livers bearing tumors. Furthermore, we found that LPS stimulated the expression and secretion of CXCL5 in Kupffer cells, but not other macrophages including peritoneal macrophage and macrophage cell line Raw264.7 cells. We hypothesized that the Kupffer cell-secreted CXCL5 in response to LPS promotes tumor progression by promoting HCC cell proliferation and regulating HCC associated immune cell infiltration. To investigate whether CXCL5 increases tumor cell proliferation, we treated wild type and Pten null hepatocytes with various concentrations of CXCL5. Our results showed that CXCL5 increased hepatocytes viability in a dose dependent manner. BrdU incorporation assay further confirmed that CXCL5 treatments induces HCC cell proliferation through its receptor CXCR2. We further demonstrated that CXCR2 knockdown led to reduced xenograft tumor growth using HepG2 cells. Additionally, we injected Pten null mice with CXCR2 inhibitor to block CXCL5 signal and observed partial response. We analyzed the immune cell profile of the responder mice vs. non-responder mice and showed that tumor inhibition is correlated with T cell infiltration. To test whether Kupffer cells regulate T cells through CXCL5, we isolated primary Kupffer cells from murine livers. We performed transwell migration assay using immune cells from murine spleens. Our results indicate that LPS stimulation in Kupffer cells reduced the ratio of migrated CD4+ T cells, while blocking CXCL5 using a CXCL5 antibody significantly increased CD4+ T cell recruitment to the LPS-stimulated Kupffer cells and moderately decreased neutrophil recruitment. Consistently, we found that recombinant CXCL5 protein reduces CD4+ T cell migration independent of neutrophils. In summary, our study suggests that Kupffer cell secreted CXCL5 reduces liver CD4+ T cell recruitment and increases liver cancer cell proliferation. Citation Format: Taojian Tu, Handan Hong, Lina He, Mario Alba, Tang Qi, Curtis T. Okamoto, Bangyan L. Stiles. Dual role of Kupffer cell secreted CXCL5 in hepatocellular carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5328.

Phenotype and Function of Cxcr5(+)Cd45ra(-)Cd4(+) T Cells Were Altered in Hbv-Related Hepatocellular Carcinoma and Elevated Serum Cxcl13 Predicted Better Prognosis

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control During Antiviral Therapy

CXCL13-mediated Recruitment of Intrahepatic CXCR5+CD8+T Cells Favors Viral Control in Chronic HBV Infection.

CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis.

Increased Cd4(+)Cd69(+)Cd25(-) T Cells In Patients With Hepatocellular Carcinoma Are Associated With Tumor Progression

Increased CCR7loPD-1hi

TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma

Correction: High Frequency of CD4CXCR5 TFH Cells in Patients with Immune-Active Chronic Hepatitis B.

[The Frequency, Phenotypes and Functions of CD4+ CD25+ Regulatory T Cells in Hepatocellular Carcinoma Patients].

Follicular Helper T Cell Exhaustion Induced by PD-L1 Expression in Hepatocellular Carcinoma Results in Impaired Cytokine Expression and B Cell Help, and is Associated with Advanced Tumor Stages.

Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in He-patocellular Carcinoma

Patients with Chronic Hepatitis C Express a High Percentage of CD4(+)CXCR5(+) T Follicular Helper Cells.

Effect of Regulatory B Cell Expansion on Tissue-Resident TPH Cells Immune Evasion in Hepatocellular Carcinoma.

Increased Circulating T Follicular Helper Cells Induced Via IL-12/21 in Patients with Acute on Chronic Hepatitis B Liver Failure

Abstract 5328: Dual role of Kupffer cell secreted CXCL5 in hepatocellular carcinoma

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling.

Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells

Identification of a FOXP3(+)CD3(+)CD56(+) Population with Immunosuppressive Function in Cancer Tissues of Human Hepatocellular Carcinoma.

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates